X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (111247) 111247
Newsletter (1825) 1825
Book Chapter (296) 296
Magazine Article (158) 158
Newspaper Article (111) 111
Dissertation (53) 53
Publication (37) 37
Book / eBook (35) 35
Conference Proceeding (35) 35
Government Document (11) 11
Web Resource (11) 11
Book Review (6) 6
Reference (6) 6
Journal / eJournal (2) 2
Paper (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (89993) 89993
female (55606) 55606
male (52532) 52532
middle aged (48005) 48005
aged (43210) 43210
adenocarcinoma (42022) 42022
oncology (39765) 39765
cancer (33645) 33645
adult (30336) 30336
adenocarcinoma - pathology (27357) 27357
prognosis (20715) 20715
adenocarcinoma - drug therapy (20223) 20223
surgery (19610) 19610
carcinoma (17368) 17368
chemotherapy (16551) 16551
aged, 80 and over (16451) 16451
neoplasm staging (15410) 15410
adenocarcinoma - surgery (15071) 15071
animals (13041) 13041
tumors (12936) 12936
treatment outcome (12763) 12763
retrospective studies (12513) 12513
survival (12471) 12471
metastasis (12323) 12323
adenocarcinoma - therapy (11880) 11880
research (10400) 10400
care and treatment (10287) 10287
adenocarcinoma - mortality (10206) 10206
follow-up studies (9528) 9528
expression (9522) 9522
antineoplastic combined chemotherapy protocols - therapeutic use (9488) 9488
survival rate (9473) 9473
analysis (9315) 9315
pancreatic cancer (9105) 9105
combined modality therapy (8967) 8967
mice (8843) 8843
adenocarcinoma - secondary (8816) 8816
medicine & public health (8754) 8754
gastroenterology & hepatology (8605) 8605
lung cancer (8421) 8421
therapy (8387) 8387
lung neoplasms - pathology (8246) 8246
adenocarcinoma - radiotherapy (8148) 8148
immunohistochemistry (8004) 8004
adenocarcinoma - genetics (7948) 7948
cell line, tumor (7936) 7936
radiotherapy (7867) 7867
pathology (7784) 7784
adenocarcinoma - metabolism (7751) 7751
health aspects (7015) 7015
diagnosis (6657) 6657
survival analysis (6542) 6542
risk factors (6459) 6459
apoptosis (6433) 6433
adenocarcinoma - diagnosis (6313) 6313
lung neoplasms - drug therapy (6255) 6255
lymphatic metastasis (6164) 6164
mutation (6028) 6028
patients (6003) 6003
disease-free survival (5552) 5552
pancreatic neoplasms - pathology (5495) 5495
colorectal cancer (5458) 5458
gene expression (5432) 5432
antineoplastic agents - therapeutic use (5402) 5402
genetic aspects (5345) 5345
cancer therapies (5341) 5341
medical prognosis (5334) 5334
time factors (5252) 5252
prostatic neoplasms - pathology (5195) 5195
stomach neoplasms - pathology (5101) 5101
lung neoplasms - genetics (4950) 4950
prostate cancer (4922) 4922
proteins (4657) 4657
metastases (4556) 4556
neoplasm metastasis (4530) 4530
development and progression (4509) 4509
carcinoma, squamous cell - pathology (4456) 4456
radiology, nuclear medicine & medical imaging (4428) 4428
biopsy (4312) 4312
medicine (4274) 4274
prospective studies (4224) 4224
cell biology (4203) 4203
chemotherapy, adjuvant (4052) 4052
neoplasm invasiveness (4012) 4012
research article (3991) 3991
fluorouracil - administration & dosage (3960) 3960
abridged index medicus (3934) 3934
oncology, experimental (3875) 3875
gene expression regulation, neoplastic (3863) 3863
stomach cancer (3795) 3795
gemcitabine (3751) 3751
esophageal cancer (3698) 3698
esophageal neoplasms - pathology (3682) 3682
disease progression (3627) 3627
kaplan-meier estimate (3600) 3600
mortality (3592) 3592
gastric cancer (3573) 3573
obstetrics & gynecology (3573) 3573
multivariate analysis (3562) 3562
hematology, oncology and palliative medicine (3547) 3547
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (106192) 106192
Japanese (3113) 3113
German (2006) 2006
French (1837) 1837
Chinese (751) 751
Spanish (732) 732
Russian (702) 702
Italian (484) 484
Polish (212) 212
Portuguese (158) 158
Hungarian (80) 80
Czech (70) 70
Korean (64) 64
Dutch (51) 51
Danish (46) 46
Romanian (44) 44
Norwegian (36) 36
Bulgarian (32) 32
Croatian (25) 25
Turkish (23) 23
Serbian (22) 22
Ukrainian (15) 15
Finnish (14) 14
Hebrew (14) 14
Swedish (13) 13
Lithuanian (9) 9
Slovak (9) 9
Icelandic (4) 4
Greek (3) 3
Persian (3) 3
Afrikaans (2) 2
Bosnian (1) 1
Catalan (1) 1
Georgian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European journal of cancer (1990), ISSN 0959-8049, 2016, Volume 68, pp. 156 - 162
...) durvalumab in combination with radiotherapy (RT) in an expansion cohort of patients included in a phase 1/2 trial at our institution... 
Hematology, Oncology and Palliative Medicine | Immunoradiotherapy | Phase 2 | Phase 1 | Radiotherapy | Anti-PD-L1 | ABSCOPAL | ONCOLOGY | MECHANISMS | PATIENT | RADIATION-THERAPY | Lymphatic Metastasis - radiotherapy | Bone Neoplasms - therapy | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Carcinoma, Transitional Cell - secondary | Radiosurgery | Bone Neoplasms - secondary | Antibodies, Monoclonal - therapeutic use | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Carcinoma, Transitional Cell - therapy | Liver Neoplasms - therapy | Eye Neoplasms - therapy | Chemoradiotherapy | Small Cell Lung Carcinoma - secondary | Breast Neoplasms - therapy | Brain Neoplasms - secondary | Neoplasms - therapy | Squamous Cell Carcinoma of Head and Neck | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | Adult | Female | Liver Neoplasms - secondary | Colonic Neoplasms - therapy | Eye Neoplasms - pathology | Head and Neck Neoplasms - therapy | Kaplan-Meier Estimate | Carcinoma, Squamous Cell - therapy | Survival Rate | Lung Neoplasms - therapy | Adenocarcinoma - secondary | Melanoma - secondary | Head and Neck Neoplasms - pathology | Disease-Free Survival | B7-H1 Antigen - antagonists & inhibitors | Adenocarcinoma - therapy | Breast Neoplasms - pathology | Colonic Neoplasms - pathology | Urinary Bladder Neoplasms - therapy | Brain Neoplasms - therapy | Radiotherapy, Conformal | Aged | Small Cell Lung Carcinoma - therapy | Melanoma - therapy | Biochemistry | Apoptosis
Journal Article
The lancet oncology, ISSN 1470-2045, 2016, Volume 17, Issue 6, pp. 747 - 756
Journal Article
The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 2, pp. 187 - 199
Summary Background We aimed to compare overall survival after standard-dose versus high-dose conformal radiotherapy with concurrent chemotherapy and the addition of cetuximab to concurrent... 
Hematology, Oncology and Palliative Medicine | ONCOLOGY | COMPETING RISK | CLINICAL-TRIALS | THERAPY ONCOLOGY GROUP | CHEMORADIATION | INDUCTION | CARCINOMA | CHEMOTHERAPY | RADIATION-THERAPY | Prognosis | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Carcinoma, Large Cell - mortality | Radiotherapy, Image-Guided | Chemoradiotherapy | Carcinoma, Large Cell - secondary | Neoplasm Metastasis | Antibodies, Monoclonal, Humanized - administration & dosage | Carcinoma, Non-Small-Cell Lung - secondary | Carcinoma, Squamous Cell - mortality | Aged, 80 and over | Adult | Female | Cetuximab | Paclitaxel - administration & dosage | Radiotherapy Dosage | Carboplatin - administration & dosage | Carcinoma, Squamous Cell - therapy | Survival Rate | Combined Modality Therapy | Lung Neoplasms - therapy | Carcinoma, Non-Small-Cell Lung - mortality | Adenocarcinoma - secondary | Carcinoma, Non-Small-Cell Lung - therapy | Adenocarcinoma - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Radiotherapy, Conformal | Carcinoma, Squamous Cell - secondary | Aged | Neoplasm Staging | Carcinoma, Large Cell - therapy | Adenocarcinoma - mortality | Antimitotic agents | Care and treatment | Chemotherapy | Dosage and administration | Lung cancer, Non-small cell | Antineoplastic agents | Radiotherapy | Cancer | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9809, pp. 2104 - 2111
Journal Article
Gynecologic oncology, ISSN 0090-8258, 2014, Volume 135, Issue 2, pp. 223 - 230
Abstract Objectives Complete surgery with no macroscopic residual disease (RD) at primary (PDS) or interval debulking surgery (IDS) is the main objective of... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Neoadjuvant chemotherapy | Number of cycles | Interval surgery | Prognosis | Epithelial ovarian cancer | Number of cycles Prognosis | SURVIVAL | TRIALS | CYTOREDUCTIVE SURGERY | METAANALYSIS | SENSITIVITY | RESIDUAL DISEASE | OBSTETRICS & GYNECOLOGY | ONCOLOGY | ADVANCED-STAGE OVARIAN | RESISTANCE | PRIMARY DEBULKING SURGERY | CARCINOMA | Adenocarcinoma - pathology | Adenocarcinoma, Mucinous - pathology | Carcinosarcoma - surgery | Humans | Middle Aged | Ovarian Neoplasms - pathology | Cystadenocarcinoma, Serous - pathology | Cystadenocarcinoma, Serous - drug therapy | Cytoreduction Surgical Procedures | Young Adult | Carcinoma, Endometrioid - surgery | Adenocarcinoma, Mucinous - surgery | Aged, 80 and over | Adult | Female | Neoadjuvant Therapy | Retrospective Studies | Adenocarcinoma, Mucinous - drug therapy | Paclitaxel - administration & dosage | Ovarian Neoplasms - drug therapy | Adenocarcinoma, Clear Cell - surgery | Carcinosarcoma - pathology | Neoplasms, Glandular and Epithelial - pathology | Reoperation | Treatment Outcome | Carcinoma, Endometrioid - drug therapy | Adenocarcinoma - drug therapy | Cystadenocarcinoma, Serous - surgery | Neoplasms, Glandular and Epithelial - surgery | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms, Glandular and Epithelial - drug therapy | Carcinoma, Ovarian Epithelial | Adenocarcinoma, Clear Cell - pathology | Aged | Carcinosarcoma - drug therapy | Platinum Compounds - administration & dosage | Carcinoma, Endometrioid - pathology | Adenocarcinoma - surgery | Adenocarcinoma, Clear Cell - drug therapy | Cohort Studies | Ovarian Neoplasms - surgery | Cancer patients | Care and treatment | Surgery | Adjuvant treatment | Ovarian cancer | Cancer | Life Sciences
Journal Article
European journal of cancer (1990), ISSN 0959-8049, 2016, Volume 57, pp. 10 - 22
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2014, Volume 90, Issue 4, pp. 819 - 827
.... We report our experience using proton beam therapy and intensity modulated radiation therapy for reirradiation in such cases, focusing on patterns of failure, criteria for patient selection, and predictors of toxicity... 
Radiology | Hematology, Oncology and Palliative Medicine | IRRADIATION | LOCAL RECURRENCE | ONCOLOGY | ALGORITHM | VOLUME | VALIDATION | RADIOTHERAPY | REGISTRATION | RETREATMENT | CARCINOMA | TUMORS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Carcinoma, Non-Small-Cell Lung - radiotherapy | Lung Neoplasms - drug therapy | Neoplasm Recurrence, Local - radiotherapy | Organs at Risk - radiation effects | Lung Neoplasms - mortality | Humans | Middle Aged | Proton Therapy - adverse effects | Salvage Therapy | Lung Neoplasms - radiotherapy | Neoplasm Recurrence, Local - drug therapy | Male | Carcinoma, Squamous Cell - radiotherapy | Neoplasm Recurrence, Local - mortality | Radiotherapy, Intensity-Modulated - adverse effects | Carcinoma, Non-Small-Cell Lung - secondary | Carcinoma, Squamous Cell - mortality | Aged, 80 and over | Adult | Female | Lung - radiation effects | Retrospective Studies | Adenocarcinoma - radiotherapy | Esophagus - radiation effects | Radiotherapy Dosage | Radiotherapy, Intensity-Modulated - methods | Adenocarcinoma - drug therapy | Carcinoma, Non-Small-Cell Lung - mortality | Adenocarcinoma - secondary | Disease-Free Survival | Carcinoma, Squamous Cell - drug therapy | Carcinoma, Squamous Cell - secondary | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Proton Therapy - methods | Retreatment - methods | Adenocarcinoma - mortality | Care and treatment | Radiation | Lung cancer, Small cell | Radiotherapy | Lung cancer, Non-small cell | Health aspects | Cancer | PATIENTS | DOSE EQUIVALENTS | NEOPLASMS | ESOPHAGUS | LUNGS | METASTASES | PROTON BEAMS | DEATH | RADIATION DOSES | TOXICITY | HISTOLOGY | CHEMOTHERAPY | RADIOLOGY AND NUCLEAR MEDICINE | SIDE EFFECTS
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 376, Issue 11, pp. 1015 - 1026
Journal Article
The lancet oncology, ISSN 1470-2045, 2016, Volume 17, Issue 7, pp. 976 - 983
Journal Article